Lance A Smith Selected Research

BTS 74 398

1/2004

The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lance A Smith Research Topics

Disease

13	Dyskinesias (Dyskinesia) 02/2014 - 09/2002
10	Parkinson Disease (Parkinson's Disease) 01/2010 - 09/2002
2	Chorea (Rheumatic Chorea) 10/2003 - 09/2002
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2006
1	Multiple System Atrophy 11/2006
1	Dystonia (Limb Dystonia) 10/2003
1	Hyperkinesis 09/2002

Drug/Important Bio-Agent (IBA)

14	Levodopa (L Dopa)FDA LinkGeneric 02/2014 - 09/2002
13	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2014 - 09/2002
5	Dopamine (Intropin)FDA LinkGeneric 01/2010 - 09/2002
4	Dopamine Agonists (Dopamine Agonist)IBA 12/2007 - 09/2002
3	Dopamine Receptors (Dopamine Receptor)IBA 01/2010 - 09/2002
3	entacapone (Comtan)FDA Link 12/2007 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 02/2014 - 11/2006
2	Carbidopa (Lodosyn)FDA LinkGeneric 01/2010 - 03/2005
2	ropinirole (Requip)FDA LinkGeneric 12/2007 - 03/2007
2	Piribedil (Trivastal)IBA 05/2006 - 09/2002
2	PiperazineIBA 09/2002 - 09/2002
1	Peptides (Polypeptides)IBA 02/2014
1	catechol (pyrocatechol)IBA 12/2007
1	BenserazideIBA 04/2007
1	NeuropeptidesIBA 04/2007
1	glycine amideIBA 04/2007
1	OsteopontinIBA 11/2006
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 09/2006
1	2- n- butyl- 9- methyl- 8- (1,2,3)triazol- 2- yl- 9H- purin- 6- ylamineIBA 09/2006
1	BTS 74 398IBA 01/2004
1	Pramipexole (Mirapex)FDA LinkGeneric 10/2003
1	Serotonin (5 Hydroxytryptamine)IBA 10/2003
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2003
1	vanoxerine (I 893)IBA 09/2002
1	brasofensineIBA 09/2002
1	Dopamine Agents (Dopaminergic Agents)IBA 09/2002

Therapy/Procedure

2	Therapeutics 01/2010 - 12/2007
1	Oral Administration 05/2006